SSR Mining Inc.

Company SSRM

Last mentioned: Feb 18, 2026

Stories mentioning SSR Mining Inc. 2

earnings Neutral

MedTech Innovation and Mining Recovery Define Q4 2025 Earnings

Beta Bionics and NeoGenomics posted strong Q4 2025 results driven by automated insulin delivery and oncology diagnostics, respectively. Meanwhile, SSR Mining focused on operational stabilization and cost discipline following a volatile fiscal year for precious metals.

3 sources
pharma Neutral

Beta Bionics and NeoGenomics Signal Strong 2026 Outlook in Q4 Results

Beta Bionics and NeoGenomics reported robust Q4 2025 results, highlighting significant commercial momentum in autonomous insulin delivery and oncology diagnostics. Both companies emphasized operational efficiency and market expansion as key drivers for the upcoming fiscal year.

3 sources